A US judge has intervened to halt a National Institutes of Health (NIH) policy that sought to reduce funding overhead for research institutions to 15%. The decision follows a lawsuit from 22 states, emphasizing the policy's potential to obstruct significant biomedical research and innovations. Historically, the NIH granted substantial support, with billions allocated to overhead costs that facilitate research operations. Critics argue this sudden cut could undermine vital disease research efforts as federal funding strategies undergo scrutiny under the current administration, driven by influential figures like Elon Musk.
The action is in response to a lawsuit filed by 22 US states earlier today contending that the policy was illegal and would cause 'cutting-edge work to cure and treat human disease' to 'grind to a halt'.
The steep cut attempted by the NIH comes as the administration of US President Donald Trump, which has partnered with billionaire and entrepreneur Elon Musk, is taking aim at federal spending and attempting to dismantle agencies such as the US Agency for International Development.
Collection
[
|
...
]